• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

    2/14/23 4:06:29 PM ET
    $SGHT
    Medical/Dental Instruments
    Health Care
    Get the next $SGHT alert in real time by email
    SC 13G/A 1 d412718dsc13ga.htm SC 13G/A SC 13G/A

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G/A

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

     

    Sight Sciences, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    82657M105

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐

    Rule 13d-1(b)

     

    ☐

    Rule 13d-1(c)

     

    ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


      1    

      Names of Reporting Persons

     

      Paul Badawi

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      5,691,953(1)

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      5,691,953(1)

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,691,953(1)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      11.8%(2)

    12  

      Type of Reporting Person

     

      IN

     

    (1)

    The Reporting Person is the beneficial owner of 5,691,953 shares of Common Stock, of which (i) 5,264,782 shares of Common Stock are held by the Reporting Person as of December 31, 2022, (ii) 21,950 shares of common stock that will be issued upon the settlement of restricted stock units on January 1, 2023, and (iii) 405,221 shares of Common Stock underlying stock options that are exercisable prior to March 1, 2023.

    (2)

    Based upon 48,151,302 shares of Common Stock outstanding as of November 4, 2022, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, that was filed with the Securities and Exchange Commission on November 10, 2022.


    ITEM 1. (a)

    Name of Issuer:

    Sight Sciences, Inc. (the “Issuer”).

    (b) Address of Issuer’s Principal Executive Offices:

    4040 Campbell Ave, Suite 100, Menlo Park, California 94025

     

    ITEM 2. (a)

    Name of Person Filing:

    This statement is filed on behalf of Paul Badawi (the “Reporting Person”).

    (b) Address or Principal Business Office:

    The business address of the Reporting Person is c/o Sight Sciences, Inc., 4040 Campbell Ave, Suite 100, Menlo Park, California 94025.

    (c) Citizenship of each Reporting Person is:

    Paul Badawi is a citizen of the United States.

    (d) Title of Class of Securities:

    Common Stock, par value $0.001 per share (“Common Stock”).

    (e) CUSIP Number:

    82657M105

     

    ITEM 3.

    Not applicable.

     

    ITEM 4.

    Ownership.

    (a-c)

     

    Reporting Person   

    Amount

    beneficially

    owned

       

    Percent

    of class:

        Sole power
    to vote or to
    direct the
    vote:
        Shared power
    to vote or to
    direct the vote:
        

    Sole

    power to

    dispose or
    to direct
    the

    disposition

    of:

       

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     

    Paul Badawi

         5,691,953 (1)      11.8 %(2)      5,691,953 (1)      0        5,691,953 (1)      0  

     

    (1)

    The Reporting Person is the beneficial owner of 5,691,953 shares of Common Stock, of which (i) 5,264,782 shares of Common Stock are held by the Reporting Person as of December 31, 2022, (ii) 21,950 shares of common stock that will be issued upon the settlement of restricted stock units on January 1, 2023, and (iii) 405,221 shares of Common Stock underlying stock options that are exercisable prior to March 1, 2023.

    (2)

    Based upon 48,151,302 shares of Common Stock outstanding as of November 4, 2022, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, that was filed with the Securities and Exchange Commission on November 10, 2022.


    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 14, 2023

     

    Paul Badawi
    /s/ Paul Badawi
    Get the next $SGHT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGHT

    DatePrice TargetRatingAnalyst
    12/6/2024$5.50Buy
    UBS
    11/4/2024$10.00 → $5.00Buy → Hold
    Lake Street
    8/21/2024$10.00Buy
    Lake Street
    9/12/2023$10.00 → $4.50Neutral → Underperform
    BofA Securities
    9/12/2023$15.00 → $5.50Overweight → Neutral
    Piper Sandler
    9/12/2023Outperform → Mkt Perform
    William Blair
    8/24/2023$12.00 → $8.40Overweight → Equal-Weight
    Morgan Stanley
    7/10/2023$15.00 → $9.00Buy → Neutral
    Citigroup
    More analyst ratings